Professional Documents
Culture Documents
2555
353-211 General Principles
for Medical Science III
4(4-0-8)
353-212 General Principles
4(3-3-7)
1
4(3-3-7)
353-231 Hematopoietic and
Lymphoreticular System
4(3-3-7)
411-324 English for
Medical Science I
3(3-0-
6)
: . .
4(4-0-8)
: Tel
sura_wng@kku.ac.th
sorujsr@kku.ac.th
043-363808, 043-348385
50
88
Conference
SG
11
3
5
6
PDM
0.5
0.5
Module
100
: ..
: . .
4(3-3-7)
wiprua@kku.ac.th
boonmars@yahoo.com
1
2
3
4
5
11
,PDM 2
Conference lab
ANS drug
SG
PDM
()
34 ( 170)
62
33 (65)
24
3 (5)
6 (30)
11
1 = 5
1 = 5
Conference lab lab
ANS drug 1 lab 5
0.5 (2.5)
0.5
0.5 (2.5)
0.5
5
275
100
21
..
55
08.00
09.00
SDL
09.00
10.00 - 11.00
-10.00
353 211: L1
Introduction to
Immunology
Preclinical
Medicine 2
11.00
-12.00
353 211:
L2
Production
and
function of
granulocyte
s, NK, mac
13.00 - 14.00
14.00 -
15.00
16.00-
353 211: L3
Production
and function
of T
lymphocytes
15.00
353 211: L4
.Production
and function
of B
lymphocytes
-16.00
SDL
17.00
SDL
353 211:
L5
Nature of
Ig
22 .
55
353 211:
L6
Antigen,
Antigenicity
and
immunogeni
city
24 .
55
3501 3506
353 211:L10-11:
Immunologic mediators
23 .
55
SDL
411 324 :
353
211:L13
Immune
2 response
2 mechanisms
(1)
353 211:L15-16
Microcirculation &
Edema
353 211:
25 . L19 Acute
55
Inflammatio
n ()
SDL
411 324 :
3501 3506
353 211:
353 211: L21
L20 Chronic Reparative
inflammatio processes
n
353
211:L22
Outcome of
inflammatio
n
353 211: L7
Innate
immunity
SDL
SDL
353 211:L17-18.Acute
Inflammation, including cells
and mediators
SDL
SDL
SDL
SDL
353 211:L23
353 211:
Introduction to L24
pharmacology Pharmacokine
tics I
2
08.00
09.00 -10.00
09.00
L353
353 211: L26
211:L25
Pharmacokinetic
Inflammatory
s II
28 . responses
55
29 .
55
353 211:
L30
Physiology
of ANS
10.00 - 11.00
11.00 -12.00
353 211:
L27
Pharmacokine
tics III
SDL
411 324 :
3501 3506
353 21:L34
Parasympatho
mimetic
drugs
353 21:L35
Parasympatholy
tic
drugs
13.00 14.00
353 211 L29
Pharmacodyna
micsII
14.00 15.00
15.00
-16.00
SDL
16.0017.00
SDL
PBL
Lab.1-2
2 Bio-Ethic
and
Laws (
)
SDL
SDL
353 211:L36-37
Neoplasia
2
31 .
55
353 211:L38-39
SDL
411 324 :
3501 3506
..55
2
2
10
PDM
. .
353 211:
353 211:
L42
General
Immunology
properties
SDL
(Summary)
of autacoids
SDL
08.00
09.00
10.00 -
11.00
09.00
-10.00
11.00
-12.00
..55
353 211:L44-45:
Hypersensitivities
411 324 :
..55
13.00 -
14.00 -
15.00
16.00-
14.00
15.00
-16.00
17.00
SDL
SDL
3501 3506
SDL
Lab. 8
353 212 Lab 2: Pharmacokinetic (Sec
02)
..55
Gen.3: Case 1 :
SG 1
SDL
chemotherapy
11
SDL
Lab.3-4
.., .
SDL
..55
411 324 :
RE
SDL
3501 3506
Lab.7
Gen.3: Case 1 :
SG 2
..55
Lab. 8
RE
SDL
SDL
SDL
Lab.7
08.00
09.00
09.00 -10.00
10.00-
11.00-
11.00
12.00
12
13.00-14.00
14.00
15.00-
16.00-
-15.00
16.00
17.00
11
..55
RE
Gen.3: Case 1 : SG 3
Case
Alterations in
immunologic
function
353
353 212:
Transplant
Lab2.
211 :L49:
rejection
Conf.
Pharmacoki
netic
SDL
353
12
..55
211:L50:
:L51:
Pharmacog
enetics
Immunomodu
lating agents
13
..55
SDL
SDL (sec.02)
353 211
411 324 :
3501 3506
SDL
4202 -
4405
SDL
350413
CPC
SDL
3507,3509-3512,3514,
3516--3522 5
SDL (sec.01)
14
411 324 :
SDL
..55
SDL
SDL
3501 3506
15
..55
SDL
SDL
SDL
353-211 General Principles for Medical Science III 353-212 General Principles for Medical
Science IV :
08.00-
18
09.00
SD
L
09.00-10.00
Exam
10.0011.00
11.00-12.00
Week 5
13.0014.00
14.00-
15.00-
15.00
16.00
SDL
MCQ 1 : Gen 3
.. 55
14
16.00-17.00
19
.. 55
Exam
SD
L
20
411 324 :
Course
orientation
353 212:
353 212:
L1
:Morphology of L2:
bacteria &
Bacterial
nutrition
requirement
genetics
.. 55 2
3501 3506
MCQ 2 : Gen 3
353 212:
L3:
Specimen
collection
for
2 2 microbiolog
Exam
Gen 3
353 212:
MEQ:
SDL
Pitfall in Neurosurgery
SDL
PCT Neuro
21
.. 55
22
.. 55
Exam Lab
SDL
parasite relationship
Patho
Lab 8
15
()
SDL
SDL
25
..
08.00-09.00
09.00-10.00
10.00-11.00
antimicrobial
(3); Macrolides,
Classification of
..
55
linicosamides,
chloramphenicols
2
26
12.00
Antimicrobial
55
11.00-
353 212:
L9:
Introduction
to Mycology
353
212:L10:
Diseases
caused by
SDL
13.00-14.00
14.00-15.00
15.0016.00
16.0017.00
SDL
411 324 :
353 212:L13:
353 212:
Systemic and
L14:
fungal infection
drugs
3501 3506
opportunistic
fungal
infections
16
Antifungal
SDL
353 212:
27
..
55
L15 :
Introduction to
28
..
55
353 212:
353 212:
Viral
Viral- host
to virology
replication
Introduction
parasitology
L19
protozoa
Medical
SDL
()
L20 :
relationship
Lab 7/,
411 324 :
SDL
3501 3506
SDL
02)
Lab 5-6/
29
Trematodes
353 212:
L24
Medical
Lab7/ ,
17
SDL
..
55
Trematodes
2
Lab 5-6/
08.00-09.00
09.00-10.00
10.00-11.00
11.00-12.00
Case 2: SG1
..
55
14.0015.00
15.00-16.00 16.00-17.00
Acanthocephalans
13.00-14.00
Lab7/ ,
353 212: Lab8 : Demons. Trematodes and
SDL
Cestodes-Acanthro, (Sec02)
Lab 5-6 /
353 212:
3
..
L27:
Microbial
353 212:
L28:
Antiseptic &
RE
411 324 :
3501 3506
Lab7/ ,
18
RE
growth
55
Disinfectant
control
..
55
..
55
Medical
Medical
nematodes
55
353 212:
L31
Antiparasitic
drugs
RE
Case 2: SG 3
RE
nematodes
Medical
(Sec.01):
Lab 7/
(Sec 02)
RE:
case
()
19
RE
Lab 5-6 /
SDL
3501 3506
411 324 :
Lab 5-6 /
353 212:
Case2: SG2
..
Cestodes-Acanthro, (Sec01)
L29
Virus(Sec.02):
Lab 7/
353 212: Lab 10 : Demons Nematodes
SDL
(Sec 01)
Lab 5-6/
08.00-
09.00-10.00
09.00
10.0011.00
11.00-
12.00
14.00-
13.00-14.00
15.00
15.0016.00
9 ..
1);
sterile technique
SDL
LAB 7
55
(Sec 02)
10
353 212:
353 212:
411 324 :
L33:
L34:
Pathophysiol Epidemiolog
ogy
y Prevention
.. 55 and
Diagnosis of
Parasitic
Infections
Control
3501 3506
Practice Grams
stain (Sec 02);
Lab 5-6/
()
16.00-19.00
PDM: Practice
SDL
2);
Lab 7/
Practice
Grams stain
(Sec0 1);
(Sec 01)
SDL
20
11
.. 55
12
MEQ
SDL
08.30-9.30
411 324 :
MCQ: ( L1 14)
3501 3506
Bacteria , Fungus,
SDL
.. 55
13
.. 55
13.00 -15.00
antibacterial + antifungal
SDL
drugs,
13.00-15.00
(spot)- stool
SDL
exam /
()
stain)
21
(Grams
Lab 5-6, 7
SDL
08.00-
09.00
09.00-10.00
10.00-
11.00-
13.00-
14.00-
15.00-
16.00-
11.00
12.00
14.00
15.00
16.00
17.00
16
.. 55
17
1
411 324 :
SDL
.. 55
3501 3506
18
Atopic dermatitis in
SDL
Children
.. 55
19
SDL
.
SDL
411 324 :
3501 3506
.. 55
22
SDL
20
SDL
SDL
.. 55
wilmot@kku.ac.th
parpra@kku.ac.th
/
23
29
60
18
25
Conference
14
PDM
0.5
SG
MEQ = 8%
0.5
100
24
= 6%
Week 10
23
..55
24
08.00-09.00
Orientation
25
12.00
L2-3:Organ structure
L1:
Embryology of and function
skin
Tissue infection
SDL
411 324 :
3501 3506
Tissue infection
infection
..55
L14
Parasitic skin
26
11.00
..55
09.00-10.00
11.00-
infection
L15
Parasitic skin
infection
L4 : Repair,
regeneration of
the skin
()
411 324 :
3501
- 3506
25
14.00-
15.00-
15.00
16.00
16.0017.00
SDL
L13 : Fungal
skin infection
SDL
13.00-14.00
10.00-
SDL
Lab.7/ ,
SDL
SDL
..55
27
..55
L16: Parasitic
Skin infection
Lab. 8/ ,
2
Lab gross /
work skill)
26
SDL
SDL
30
..55
08.0009.00
09.0010.00
10.0011.00
L17-18:
CASE 1: SG 1
Dermal inflammation
13.00-14.00
14.0015.00
15.0016.00
Lab. 5-6/
Lab 3: Histology and embryology of
the skin (Sec 02)
16.0017.00
SDL
Lab. 8/ ,
RE
31
2
..55
1
..55
L19-20 Dermal
RE
CASE 1: SG 2
SDL
inflammation
411 324 :
3501 - 3506
SDL
SDL
27
SDL
..55
3
..55
28
08.0009.00
L 21
..55
09.0010.00
L22
Trauma
Tumor
and skin
disorder
injury
10.0011.00
L23
Insect bite
..55
..55
13.00-14.00
L24
L25
Antifungal
Antihistamin
& antiviral
agents
Tumor disorder
2 SDL
CASE 2: SG 1
3501 - 3506
L28
L29
Topical
Corticostero
drugs for
common
id
bacterial
and
parasitic
skin disease
29
16.00
16.0017.00
SDL
411 324 :
15.00
15.00-
L26-27
14.00-
11.00-12.00
Week 12
SDL
Lab. 8/
SDL
SDL
RE
RE
..55
411 324 :
3501 - 3506
Lab.7/ ,
SDL
(Sec 01):SDL
Lab5: Pathology(Sec 02)
10
..55
CASE 2: SG 2
RE : Case summary
Lab. 8/
SDL
Lab.7/,
Week 13
08.00-
09.00-
10.00-
11.00-
13.00-
14.00-
15.00-
16.00-
09.00
10.00
11.00
12.00
14.00
15.00
16.00
17.00
30
13
..54
411 324 :
14
SDL
..54
SDL
3501 -
3506
15
..54
SDL
MCQ
411 324 :
16
17
SDL
..54
SDL
3501 -
MEQ
3506
SDL
SDL
SDL
..54
31
SDL
SDL
: ...
: Tel
4(3-3-7)
tipeka@kku.ac.th
chapie@kku.ac.th
043-363808, 043-348385
69.65
35
35
27
17.91
MCQ
MCQ:
5
Spot test
1, 3, 4, 6, 7, 9
32
Practice
3
4
11.94
0.5
100
8.00-9.00
9.00-10.00
10.00-11.00
33
14.00-15.00
15.00-
16.00-
16.00
17.00
Orientation
20
..55
21
..55
22
..55
and
lymphoid
2
L6: RBC 3 :
hemoglobi
n
L1: Blood
SDL
organs 1
L3: Blood
L4: RBC 1 :
organs2
organs 3
lymphoid
and lymphoid
Delvelopment
L5: RBC 2 :
Hemoglobin
composition
2
Systemic
infection
SDL
411 324 :
SDL
L7 :
SDL
L8-10: Hemostasis
3501 3506
SDL
L11: SIRS,
L12:Cytomegalo L13:
virus, Epstein-
Dengue and
L14:
Syndrome
Chikunguny
Disease of the
Sepsis
HTLV-I
a
2
2
2
34
Hemolytic
Newborn
SDL
L16: AIDS
disorder1
23 .
55
SDL
411 324 :
L17-18:
3501 3506
SDL
SDL
SDL
SDL
24
disorder2
LAB 8/
..55 WBC
L21:
disease
and diagnosis
LAB 2:
WBC (SEC 02)
2 LAB 7/
08.00-9.00
L22:
27
09.00-10.00
10.00-11.00
11.00-
12.00-
12.00
13.00
(SEC 01)
Morphology of
LAB 5, 6/
red cell disorder LAB 1 Blood and lymphoid organ (SEC 02)
35
13.00-14.00
: Week 15
14.0015.00
15.00-16.00
L25:
disorder
Hemostasis
disorder
16.0017.00
SDL
..55
L26:
28
..55
LAB 8/
L27: (For
Hemostasis
LAB 3,7)
disorder
SDL
411 324 :
3501 3506
LAB 5-6/ .
SDL
SDL
(SEC 02)
..55
L28:Symptoms
and signs in
30
..55
CASE 1: SG 1
29
Hematopoietic
and
RE
411 324 :
3501 3506
LAB 3: ABO Blood grouping and
Antiglobulin test (SEC 02)
LAB 7./
SDL (SEC 01)
Lymphoreticula
r System
2
36
SDL
SDL
31
L29: (For
LAB5)
Screening tests
for bleeding
disorder
..55
L30:Trypan
osomiasis,
Leishmanias
is,
Babesiosis,
Filaria, and
Schstosomia
sis
..55
8.00-9.00
9.00-10.00
L32:
LAB 4
RBC,
WBC
(SEC 01)
LAB
8/ , .
SDL
SDL
LAB 8/ ,
L31: Malaria
11.00-12.00
12.0013.00
: Week 16
13.00-14.00
14.0015.00
15.0016.00
16.0017.00
SDL
CASE 1: SG
411 324 :
SDL
3501 3506
..55
..55
L33: Blood
Components
Therapy
RE
L34:
LAB 1-2/
LAB 6 Malaria, filariasis and
hemoflagellates. (SEC 02)
L35:
Transfusion
Reaction
L36:
Chemothera
py and
6
immunosupp
..55 ressive
drugs
LAB 7:
(SEC 01)
LAB 5-6/
L37:
Anticoagul
anti
platelet
411 324 :
3501 3506
CASE 1: SG 3
RE
2
38
SDL
L38:
ant and
SDL
SDL
SDL
LAB 7:
. (SEC 02)
LAB 3-4/
SDL
..55
8.00-9.00
9.00-10.00
10.00-11.00
11.00-12.00 12-13
15.00
15.00-16.00
16.0017.00
( SEC 01)
10
SDL
..55
LAB 5- 6/
SDL
LAB 9:
( SEC 02)
LAB 8/
..55
14.00
14.00-
LAB 8:
11
13.00-
: Week 17
411 324 :
SDL
SDL
3501 3506
LAB 9:
(SEC 01)
LAB 8/
LAB 8:
SDL
( SEC 02)
LAB 5- 6/
12
SDL
SDL
..55
CPC
39
SDL
13
411 324 :
SDL
..55
3501 3506
10.30-
14
..55
SDL
MEQ
(SEC 01)
SPOT TEST
11.30
SDL
Blood
examination
SDL
LAB 7
for malaria
LAB 5, 6
15 -30
MCQ
2555
2555
40
SDL
(SEC 02)
SPOT TEST
LAB 7
LAB 5, 6